ImmunityBio, Inc. IBRX
At closeNov 12, 2026, 5:04 PM EST
After hours · Nov 12, 5:04 PM ET
- YTD
- +206.57%
- 1 year
- +194.66%
Discussion (3506)
Sign in to join the discussion
ImmunityBio will be profitable with just full bladder cancer approval worldwide.
As more approvals occur ????
Next earnings date 5-11-2026 the earnings and sales numbers should be terrific so time to load up. Papillary approval should be soon. ? ride will follow.
Kerry thanks for the post. we must keep the faith and remember every person on this board may need Anktiva someday. Think about it, if you don't die from a heart attack or stroke good chance you will need Anktiva
Someday we will be rewarded huge is my belief. Told myself no more at 400,000 shares but ended up at 550,000 those extra 150,000 will equal at $50 will be 7.5 million :) 550000x50= 27.5 million Get R Done
Can't buy more have 550,000
What will the price be in 1-5 years? $15 $20 $35 $50 $100
Know what you own and why and if the story is the same relax and be patient
ImmunityBio will prevail over time. Its news and potentials are put down suppressed to protect BP and MSM ad $$$$ from BP.
ImmunityBio and its study results will win in the end.
Plus the world has many counties and billions of people to treat and cure.
America's 350 million is about 5%
I bought 550,000 shares over 3 years never sold 1 share ever
Why???? The science.... Dr. PSS and I know I will need ImmunityBio if I don't die from a heart attack or stroke
Plus I want to make 25-50 million
Sepsis is an infection that has overwhelmed the immune system. So Anktiva if it can restore the immune system, which is actual what it does, it should be a dramatic tool to treat sepsis and save lives......
Why would I care about 7.50 8 10 12 we will see $100 plus some day
Buy hold to the $8 lmao how about $50-$100
